Pfizer OncologyDirector, Value and Evidence
Expert Perspectives on the Role of Real-World Evidence, Patient-Reported Outcomes, and Economic Models in Oncology Formulary Decision and Regulatory Submissions for FDA Approval
A Q&A With Bhakti Arondekar, PhD, MBA; Alexander Niyazov, PharmD, MPH; and Jay Weaver, PharmD, MPH